Atlas Private Wealth Advisors - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 156 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.

Quarter-by-quarter ownership
Atlas Private Wealth Advisors ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$20,000
-64.9%
3,500
-36.4%
0.01%
-67.7%
Q2 2021$57,000
-60.7%
5,500
-60.1%
0.03%
-61.7%
Q1 2021$145,000
-79.0%
13,780
-69.1%
0.08%
-82.5%
Q4 2020$691,000
-0.7%
44,640
-6.3%
0.46%
-20.1%
Q3 2020$696,000
-24.4%
47,640
-2.1%
0.58%
-29.1%
Q2 2020$921,00048,6400.82%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders